These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4670480)

  • 1. Minocycline in the chemoprophylaxis of meningococcal disease.
    Guttler RB; Beaty HN
    Antimicrob Agents Chemother; 1972 May; 1(5):397-402. PubMed ID: 4670480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampin and minocycline in meningococcal disease.
    Beaty HN
    Rev Infect Dis; 1983; 5 Suppl 3():S451-8. PubMed ID: 6415780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chemoprophylactic use of rifampin and minocycline on rates of carriage of Neisseria meningitidis in army recruits in Finland.
    Sivonen A; Renkonen OV; Weckström P; Koskenvuo K; Raunio V; Mäkelä PH
    J Infect Dis; 1978 Mar; 137(3):238-44. PubMed ID: 416147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal disease in Italy.
    Stroffolini T; Congiu ME; Occhionero M; Mastrantonio P
    J Infect; 1989 Jul; 19(1):69-74. PubMed ID: 2506286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprophylaxis for Neisseria meningitidis in an isolated Arctic community.
    Nicolle LE; Postl B; Kotelewetz E; Remillard F; Bourgault AM; Albritton W; Harding GK; Ronald A
    J Infect Dis; 1982 Jan; 145(1):103-9. PubMed ID: 6798128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline for prophylaxis of infection with Neisseria meningitidis: high rate of side effects in recipients.
    Drew TM; Altman R; Black K; Goldfield M
    J Infect Dis; 1976 Feb; 133(2):194-8. PubMed ID: 812929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of meningococcal meningitis].
    Wiesmann E; Rosselet F
    Schweiz Med Wochenschr; 1977 Jan; 107(1):13-6. PubMed ID: 401542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of an outbreak of group C meningococcal meningitis with a polysaccharide vaccine.
    Masterton RG; Youngs ER; Wardle JC; Croft KF; Jones DM
    J Infect; 1988 Sep; 17(2):177-82. PubMed ID: 3141518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of group-A meningococcal vaccine in army recruits in Finland.
    Mäkelä PH; Käyhty H; Weckström P; Sivonen A; Renkonen OV
    Lancet; 1975 Nov; 2(7941):883-6. PubMed ID: 53370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MENINGOCOCCAL INFECTIONS. FORT ORD AND CALIFORNIA.
    BROWN JW; CONDIT PK
    Calif Med; 1965 Mar; 102(3):171-80. PubMed ID: 14254973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal disease and its control.
    Riley HD
    South Med J; 1973 Jan; 66(1):107-14. PubMed ID: 4630520
    [No Abstract]   [Full Text] [Related]  

  • 12. Meningococcal C conjugate vaccine effectiveness before and during an outbreak of invasive meningococcal disease due to Neisseria meningitidis serogroup C/cc11, Tuscany, Italy.
    Pezzotti P; Miglietta A; Neri A; Fazio C; Vacca P; Voller F; Rezza G; Stefanelli P
    Vaccine; 2018 Jul; 36(29):4222-4227. PubMed ID: 29895504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary cases of meningococcal disease in The Netherlands, 1989-1990; a reappraisal of chemoprophylaxis].
    Scholten RJ; Bijlmer HA; Dankert J; Valkenburg HA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1505-8. PubMed ID: 8366938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination.
    Pearce MC; Sheridan JW; Jones DM; Lawrence GW; Murphy DM; Masutti B; McCosker C; Douglas V; George D; O'Keefe A
    Lancet; 1995 Jul; 346(8966):20-3. PubMed ID: 7603139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vestibular reactions associated with minocycline.
    Jacobson JA; Daniel B
    Antimicrob Agents Chemother; 1975 Oct; 8(4):453-6. PubMed ID: 1081373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distressing side-effects of minocycline hydrochloride.
    Fanning WL; Gump DW
    Arch Intern Med; 1976 Jul; 136(7):761-2. PubMed ID: 938165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemic meningococcal meningitis in central Australia, 1987-1991.
    Patel MS; Merianos A; Hanna JN; Vartto K; Tait P; Morey F; Jayathissa S
    Med J Aust; 1993 Mar; 158(5):336-40. PubMed ID: 7605395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal carriage, meningococcal disease and vaccination.
    Hassan-King MK; Wall RA; Greenwood BM
    J Infect; 1988 Jan; 16(1):55-9. PubMed ID: 3130424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of meningococcal infection in the African meningitis belt by selective vaccination.
    Greenwood BM; Wali SS
    Lancet; 1980 Apr; 1(8171):729-32. PubMed ID: 6103155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.